AliveCor announces availability of its Mobile ECG in Canada

334

AliveCor’s Mobile ECG has now been made available for patients and physicians in Canada. With the AliveCor Mobile ECG and the AliveECG app users can detect the presence of atrial fibrillation in an electrocardiogram (ECG or EKG) and manage their heart health with an US Food and Drug Administration-cleared and Health Canada-licensed electrocardiogram ECG monitor, anywhere and at any time.

Due to Canada’s aging population, atrial fibrillation is a growing problem. One-in-four Canadians over 40 years of age will suffer from the condition in their lifetime. Stroke is a leading cause of death and disability in Canada and is a devastating condition, causing stress for both patients and their families and costing the healthcare system more than US$2.5bn annually. Additionally, the death rate of atrial fibrillation-related strokes is twice as high as from strokes unrelated to it. That said, three out of four strokes can be prevented if detected and treated.

“We are excited to be able to provide credible healthcare solutions that stop the unnecessary loss of life driven by undiagnosed and under-managed heart arrhythmias, which are on the rise in Canada. The availability of mobile devices like the AliveCor Mobile ECG will be of great benefit to those affected, their families, and the healthcare system,” said Euan Thomson, chief executive officer of AliveCor. “Being able to understand what is going on inside heart disease through data analytics has the potential to change the way we think about and participate in our healthcare.”

AliveCor has seen significant growth throughout the past four years including expanded regulatory clearances, the launch of three algorithms, and recently surpassing 2.5 million ECGs recorded into the AliveCor database that are being used to develop powerful insights about heart health. Additionally, the company more than doubled the number of regular users and recordings in the last year and continues to expand globally entering nine new countries in 2015.

“We have seen the global impact of the AliveCor Mobile ECG for both patients, physicians and caregivers and are thrilled that it is now available in Canada, a vital community for us and our fight against heart arrhythmias,” said Trudie Lobban founder and chief executive officer of the Association, Arrhythmia Alliance and STARS (Syncope Trust). “This is an effective and efficient tool to help monitor and manage arrhythmias and we look forward to their continued expansion.”

(Visited 61 times, 1 visits today)